VKH
LSTA icon

Virtu KCG Holdings’s Lisata Therapeutics LSTA Stock Holding History

Virtu KCG Holdings’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,419
Closed -$183K – 3236
2017
Q1 		$183K Buy
2,419
+1,033
+75% +$71.6K 0.01% 2481
2016
Q4 		$59K Buy
+1,386
New +$79.6K ﹤0.01% 3053
2016
Q2 		– Sell
-225
Closed -$25K – 3172
2016
Q1 		$25K Buy
225
+117
+108% +$11.5K ﹤0.01% 2570
2015
Q4 		$18K Sell
108
-242
-69% -$44.4K ﹤0.01% 3321
2015
Q3 		$78K Sell
350
-38
-10% -$9.53K ﹤0.01% 2896
2015
Q2 		$109K Buy
388
+132
+52% +$49K ﹤0.01% 2878
2015
Q1 		$98K Buy
256
+136
+113% +$73.7K ﹤0.01% 2657
2014
Q4 		$68K Buy
+120
New +$81.7K ﹤0.01% 3353
2014
Q3 		– Sell
-74
Closed -$72K – 3858
2014
Q2 		$72K Buy
+74
New +$71.9K ﹤0.01% 3361
2014
Q1 		– Sell
-101
Closed -$103K – 3827
2013
Q4 		$103K Buy
101
+28
+38% +$27.7K ﹤0.01% 3428
2013
Q3 		$93K Buy
+73
New +$81.1K ﹤0.01% 3388

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

Virtu KCG Holdings's LSTA Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Lisata Therapeutics (LSTA) in Q2 2017, closing a stake of 2,419 shares — an estimated $183K sold.

Virtu KCG Holdings first reported a position in LSTA in Q3 2013 and held it in 11 quarters. The position peaked at $183K in Q1 2017. 25 funds tracked by Wall St. Rank hold LSTA as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Lisata Therapeutics position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 2,419 Lisata Therapeutics shares in Q2 2017, an estimated $183K.
  • Virtu KCG Holdings first reported a position in Lisata Therapeutics in Q3 2013 and held it in 11 quarters.
  • Virtu KCG Holdings's Lisata Therapeutics position peaked at $183K in Q1 2017.
  • 25 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.